196 related articles for article (PubMed ID: 18853059)
1. Based treatment algorithm for essencial hypertension with olmesartan medoxomil.
Gomes MA; Feitosa AD; Oigman W; Ribeiro JM; Moriguchi EH; Saraiva JF; Précoma DB; Ribeiro AB; Amodeo C; Brandão AA
Arq Bras Cardiol; 2008 Sep; 91(3):168-76, 185-93. PubMed ID: 18853059
[TBL] [Abstract][Full Text] [Related]
2. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
Neutel JM; Smith DH; Silfani TN; Lee Y; Weber MA
J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
Nesbitt SD; Shojaee A; Maa JF; Weir MR
J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Chrysant SG; Chavanu KJ; Xu J
Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Volpe M; Brommer P; Haag U; Miele C
Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
Volpe M; Miele C; Haag U
Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
10. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
13. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
Kereiakes DJ; Maa JF; Shojaee A; Dubiel R
Am J Cardiovasc Drugs; 2010; 10(4):239-46. PubMed ID: 20653330
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
15. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
Ram CV
Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):9-19. PubMed ID: 21166525
[TBL] [Abstract][Full Text] [Related]
16. Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
Tocci G; Paneni F; Passerini J; Volpe M
Expert Opin Pharmacother; 2012 Dec; 13(18):2687-97. PubMed ID: 23170911
[TBL] [Abstract][Full Text] [Related]
17. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
Rump LC; Sellin L
Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.
Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
J Clin Hypertens (Greenwich); 2012 Mar; 14(3):149-57. PubMed ID: 22372774
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]